TOP STORIES

• REGULATORY Nichi-Iko to Get Business Suspension Order on March 3
  March 2, 2021

• BUSINESS Takeda to Offload 4 Diabetes Meds in Japan to Teijin for 133 Billion Yen
  March 1, 2021

• REGULATORY Govt to Deliver 1st COVID-19 Vaccine Dose for 3.7 Million HCPs in April: Minister
  March 1, 2021

• REGULATORY Japan Research Group to Wrap Up Report on Clinical Trials for Cannabis-Derived Drugs by March-End
  February 26, 2021

• BUSINESS Meiji to Discontinue Sale of Kobayashi Kako Products after Biz Suspension
  February 26, 2021

• BUSINESS MSD’s 9-Valent HPV Vaccine Now Available in Japan
  February 25, 2021

• REGULATORY Japan to Start Elderly Vaccine Rollout from April 12: Minister
  February 25, 2021

• BUSINESS Takeda Launches Japan PI/II Trial of Novavax COVID-19 Vaccine
  February 25, 2021

• REGULATORY MHLW to Revise Dyslipidemia Drug Development Guideline for 1st Time in 30 Years
  February 25, 2021

• BUSINESS Japan Pharma Market Shrinks 2.4% on COVID-19, Price Cuts: IQVIA
  February 24, 2021

• REGULATORY LDP to Set Up Project Team to Strengthen Pharma Sector, Eyes Proposal in May
  February 22, 2021

• ORGANIZATION PhRMA Japan Chief Urges Govt to Return to Pro-Innovation Path, Airs Grievances over Decision-Making on Off-Year Price Cuts
  February 19, 2021

• BUSINESS Mitsubishi Tanabe Accelerating Drug Discovery via Open Innovation, Early-Stage Data Sharing
  February 18, 2021

• REGULATORY Celgene’s CAR-T Liso-Cel Now in Line for Possible March Approval in Japan
  February 18, 2021

• REGULATORY Japan Launches COVID-19 Vaccination Program
  February 18, 2021

• BUSINESS Novo Training Its Sights on Oral Diabetes Market with Rybelsus, Not Switches from GLP-1 Injectables
  February 17, 2021

• REGULATORY COVID-19 Vaccine Being Rolled Out for 40,000 Healthcare Workers in Japan
  February 17, 2021

• BUSINESS Shionogi Pharma Set to Expand CDMO Biz with Continuous Manufacturing, Eyes 10 Billion Yen Sales in FY2024
  February 17, 2021

• REGULATORY 17 Firms Get Approval for Cymbalta Generics, June Listing Eyed
  February 16, 2021

• REGULATORY PMDA Review Report: Pfizer Vaccine’s Efficacy for Variants Not Gauged in Clinical Trials, Continued Info Collection Needed
  February 16, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 94
• 95
• 96
• 97
• 98
• 99
• 100
• 101
• 102
• …
• Next ›
• 最終 »